✦ LIBER ✦

Is pancreastatin (33–49) biologically active in vitro?

✍ Scribed by G. Mulholland; P. Anderson; J.E.S. Ardill; E.R. Trimble; K.D. Buchanan

Book ID: 118398759
Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 69 KB
Volume: 30
Category: Article
ISSN: 0167-0115
DOI: 10.1016/0167-0115(90)90164-r

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pancreastatin (33–49) enhances the primi

Pancreastatin (33–49) enhances the priming effect of glucose in the rat pancreas

✍ V. Sánchez-Margalet; R. Goberna 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 174 KB

Pancreastatin and its 33–49 C-terminal f

Pancreastatin and its 33–49 C-terminal fragment inhibit glucagon-stimulated insulin in vivo

✍ Victor Sánchez-Margalet; Juan R. Calvo; Miguel Lucas; Raimundo Goberna 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 162 KB

In vitro investigation of biologically a

In vitro investigation of biologically active substances and medicinal preparations

✍ V.A. Dubinskaya; S.G. Skuridin; N.A. Polyakov; Yu.M. Evdokimov; V.A. Bykov 📂 Article 📅 2009 🏛 Elsevier 🌐 English ⚖ 66 KB

Soluble Interleukin 6 Receptor is Biolog

Soluble Interleukin 6 Receptor is Biologically Active In Vivo

✍ Andrzej Mackiewicz; Maciej Wiznerowicz; Elke Roeb; Aldona Karczewska; Jerzy Nowa 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 476 KB

Endothelin-1 is biologically active in e

Endothelin-1 is biologically active in experimental rat obliterative bronchiolitis

✍ V.P Pulkkinen; J.M Tikkanen; K.B Lemström; P.K Koskinen 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Pancreatic cancer cell-derived vascular

Pancreatic cancer cell-derived vascular endothelial growth factor is biologically active in vitro and enhances tumorigenicity in vivo

✍ Jianying Luo; Ping Guo; Kei Matsuda; Nhan Truong; Annie Lee; Carlene Chun; Shi-Y 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 373 KB 👁 1 views

Vascular endothelial growth factor (VEGF) is a potent angiogenic stimulator that acts by binding to high-affinity transmembrane receptors. Although both VEGF and its receptors are overexpressed in human pancreatic ductal adenocarcinoma (PDAC), this malignancy is not generally considered to be highly